Fanconi Syndrome in Patients With Human Immunodeficiency Virus Treated With Tenofovir-Based Antiretroviral Therapy: A Systematic Literature Review

医学 中止 内科学 替诺福韦-阿拉芬酰胺 利托那韦 范科尼综合征 临床试验 观察研究 入射(几何) 儿科 病毒载量 抗逆转录病毒疗法 人类免疫缺陷病毒(HIV) 免疫学 肾 物理 光学
作者
Mrinmayee Joshi,Brendan J. Clark,Todd A. Lee
出处
期刊:Annals of Pharmacotherapy [SAGE Publishing]
卷期号:58 (8): 857-869 被引量:10
标识
DOI:10.1177/10600280231206703
摘要

OBJECTIVE: Several cases of Fanconi syndrome (FS), a severe form of nephrotoxicity, have been reported in patients with HIV on tenofovir-containing antiretroviral therapy. A systematic review of the published literature on tenofovir-related FS in patients with HIV was conducted. DATA SOURCES: PubMed and Embase were queried to identify articles in English published between January 2005 and June 2023, reporting tenofovir-related FS in adults with HIV. Preclinical studies, conference/poster abstracts, commentaries and responses, and review papers were excluded. STUDY SELECTION AND DATA EXTRACTION: Of the 256 articles screened, 57 met the inclusion criteria. These comprised 37 case reports, 11 case series, 1 cross-sectional study, 1 case-control study, 4 cohort studies, 1 single-arm open-label clinical trial, 1 sub-analysis of clinical trials, and 1 pooled analysis of clinical trials. DATA SYNTHESIS: Among 56 cases on which information was abstracted, median age at FS diagnosis was 50 years, 51.8% were men, and duration of tenofovir use ranged from 6 weeks to 11 years. Ritonavir was co-prescribed in almost half the cases. In observational and interventional studies, incidence of FS was low. Many studies reported resolution of FS symptoms after tenofovir discontinuation. All FS occurrences were identified in those on tenofovir disoproxil fumarate (TDF), except for one patient on tenofovir alafenamide (TAF). RELEVANCE TO PATIENT CARE AND CLINICAL PRACTICE: Continuous monitoring of signs and symptoms of renal and bone toxicity is essential for patients with HIV on tenofovir-containing therapy. CONCLUSIONS: Occurrence of FS is low in patients with HIV treated with tenofovir-based regimens. Concomitant use of ritonavir may increase risk of FS. TAF may be a safer alternative than TDF in terms of nephrotoxicity.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
aajhajkahna的应助被rsd采纳,获得10
刚刚
YZJing完成签到,获得积分10
1秒前
1秒前
liketiamo完成签到 ,获得积分10
1秒前
赵琪完成签到,获得积分10
1秒前
zyy发布了新的文献求助10
2秒前
今后的应助被tang采纳,获得10
2秒前
sparks完成签到,获得积分10
2秒前
2秒前
三月烟雨发布了新的文献求助10
2秒前
Starry完成签到,获得积分10
2秒前
麤七发布了新的文献求助20
2秒前
阿盛发布了新的文献求助10
2秒前
Ttttt发布了新的文献求助10
2秒前
正直三颜完成签到,获得积分10
2秒前
饕餮完成签到,获得积分10
3秒前
wss发布了新的文献求助10
3秒前
顺利的梦松完成签到 ,获得积分10
3秒前
施tx完成签到 ,获得积分10
3秒前
3秒前
Hello的应助被11111采纳,获得10
3秒前
栀子完成签到,获得积分10
4秒前
自然完成签到,获得积分10
4秒前
BTim完成签到,获得积分10
5秒前
5秒前
5秒前
背锅侠发布了新的文献求助10
5秒前
6秒前
宥沐发布了新的文献求助10
6秒前
李健的应助被zz采纳,获得10
6秒前
三月烟雨完成签到,获得积分10
7秒前
7秒前
null的应助被科研通管家采纳,获得10
7秒前
打打的应助被科研通管家采纳,获得10
7秒前
机智雪糕完成签到,获得积分10
7秒前
科研通AI2S的应助被科研通管家采纳,获得10
7秒前
风吹麦浪的应助被科研通管家采纳,获得20
7秒前
369ninja的应助被tomatoGG采纳,获得10
7秒前
null的应助被科研通管家采纳,获得10
7秒前
7秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1500
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
Analyses de reconnaissances de dettes passées devant les échevins d'Ypres (1249-1291) 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8159542
求助须知:如何正确求助?哪些是违规求助? 9555044
关于积分的说明 21724263
捐赠科研通 7749434
什么是DOI,文献DOI怎么找? 3427246
关于科研通互助平台的介绍 2552263
邀请新用户注册赠送积分活动 2471618